論文・総説 - 岡田　隆平

分割表示 >> ／  全件表示  84 件中 1 - 84 件目

  1. Atsushi Kaida, Yuriko Igarashi, Hitomi Nojima, Mio Nakayama, Ryuhei Okada, Ryosuke Takahashi, Hisataka Kobayashi, Masahiko Miura. Uncovering cell cycle-dependent effects on cell survival in near-infrared photoimmunotherapy. Experimental Cell Research. 2025.05; 448 (2): 114570. ( PubMed, DOI )

  2. Shuhei Okuyama, Daiki Fujimura, Aki Furusawa, Hiroshi Fukushima, Ryuhei Okada, Tairo Ogura, Masayuki Nishimura, Peter L Choyke, Hisataka Kobayashi. Urinary IR700 Ligand as an Early Biomarker of Therapeutic Efficacy of Near-Infrared Photoimmunotherapy. ACS Omega. 2025.02; 10 (7): 6983-6991. ( PubMed, DOI )

  3. Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi. Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2024.12; ( PubMed, DOI )

  4. Ryuhei Okada, Taku Ito, Hiroaki Kawabe, Takeshi Tsutsumi, Takahiro Asakage. Mixed reality-supported near-infrared photoimmunotherapy for oropharyngeal cancer: a case report. Ann Med Surg (Lond). 2024.09; 86 (9): 5551-5556. ( PubMed, DOI )

  5. Fuyuki F Inagaki, Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima, Seiichiro Takao, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi. Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Cancer Sci. 2024.07; 115 (7): 2396-2409. ( PubMed, DOI )

  6. Yusuke Mizuno, Ryuhei Okada, Susumu Kirimura, Ryoichi Yoshimura, Takahiro Asakage. A Case of Malignant Transformation of Recurrent Respiratory Papillomatosis That Was Effectively Treated with Pembrolizumab Case Rep Oncol. 2024.07; 17 (1): 734-740. ( DOI )

  7. Fujikawa T, Ito T, Okada R, Sawada M, Mohri K, Tateishi Y, Takahashi R, Asakage T, Tsutsumi T. Combined genetic polymorphisms of the GSTT1 and NRF2 genes increase susceptibility to cisplatin-induced ototoxicity: A preliminary study. Hearing research. 2024.04; 445 108995. ( PubMed, DOI )

  8. Shigeru Kondo, Ryuhei Okada, Yosuke Ariizumi, Takashi Kurita, Hiroshi Shintaku, Takahiro Asakage. A Case of Syphilis Suspected Preoperatively as a Case of Tongue Cancer. Case Rep Otolaryngol. 2023.11; 2023 9469814. ( PubMed, DOI )

  9. Naoyuki Sakihama, Ryuhei Okada, Naoto Takahashi, Naoki Fushimi, Tomoki Ooka, Hiroaki Kawabe, Yosuke Ariizumi, Kazuchika Ohno, Yutaka Ueki, Niro Tayama, Takeshi Tsutsumi, Takahiro Asakage. Post-intubation laryngeal injury after COVID-19 treatment causing dyspnea: A report of six cases. Auris Nasus Larynx. 2023.10; 50 (5): 816-820. ( PubMed, DOI )

  10. Takumi Kumai, Hirotaka Shinomiya, Hirofumi Shibata, Hideaki Takahashi, Toshihiro Kishikawa, Ryuhei Okada, Shigeharu Fujieda, Masafumi Sakashita. Translational research in head and neck cancer: Molecular and immunological updates. Auris Nasus Larynx. 2023.08; 51 (2): 391-400. ( PubMed, DOI )

  11. Ryuhei Okada. [Ⅴ. Future Prospects of Photoimmunotherapy]. Gan To Kagaku Ryoho. 2023.07; 50 (7): 794-798. ( PubMed )

  12. Fuyuki F Inagaki, Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Takuya Kato, Daiki Fujimura, Shuhei Okuyama, Hiroshi Fukushima, Seiichiro Takao, Peter L Choyke, Hisataka Kobayashi. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases. Biomed Pharmacother. 2023.04; 160 114390. ( PubMed, DOI )

  13. Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi. Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts. Mol Cancer Ther. 2023.01; 22 (1): 75-88. ( PubMed, DOI )

  14. Moriya T, Hashimoto M, Matsushita H, Masuyama S, Yoshida R, Okada R, Furusawa A, Fujimura D, Wakiyama H, Kato T, Choyke PL, Kusumoto Y, Chtanova T, Kobayashi H, Tomura M.. Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration Cancer Immunology Immunotherapy. 2022.12; 71 (12): 3099-3106. ( PubMed )

  15. Wakiyama H, Furusawa A, Okada R, Inagaki F, Kato T, Furumoto H, Fukushima H, Okuyama S, Choyke PL, Kobayashi H.. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers Cancer Immunology Immunotherapy. 2022.12; 71 (12): 2869-2879. ( PubMed )

  16. Takuya Kato, Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Seiichiro Takao, Peter L Choyke, Hisataka Kobayashi. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response. Oncoimmunology. 2022.11; 11 (1): 2152248. ( PubMed, DOI )

  17. Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi. Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy. Cancer Immunol Res. 2022.11; 10 (11): 1386-1397. ( PubMed, DOI )

  18. Kato T, Okada R, Furusawa A, Wakiyama H, Furumoto H, Fukushima H, Okuyama S, Choyke PL, Kobayashi H.. Comparison of the Effectiveness of IgG Antibody versus F(ab') 2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy Molecular Pharmaceutics. 2022.10; 19 (10): 3600-3611. ( PubMed )

  19. Fukushima H, Kato T, Furusawa A, Okada R, Wakiyama H, Furumoto H, Okuyama S, Kondo E, Choyke PL, Kobayashi H.. Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer Cancer Science. 2022.09; 113 (9): 3180-3192. ( PubMed )

  20. Fuyuki F Inagaki, Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi. Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin. Pharmaceutics. 2022.09; 14 (10): 2037. ( PubMed, DOI )

  21. Okada R, Kato T, Furusawa A, Inagaki F, Wakiyama H, Fujimura D, Okuyama S, Furumoto H, Fukushima H, Choyke PL, Kobayashi H.. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy Cancer Immunology Immunotherapy. 2022.08; 71 (8): 1877-1887. ( PubMed )

  22. Furumoto H, Okada R, Kato T, Wakiyama H, Inagaki F, Fukushima H, Okuyama S, Furusawa A, Choyke PL, Kobayashi H.. Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy Cancers. 2022.08; 14 (16): 4042-402. ( PubMed )

  23. Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Hideyuki Furumoto, Hiroshi Fukushima, Shuhei Okuyama, Peter L Choyke, Hisataka Kobayashi. CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model Oncoimmunology. 2022.01; 11 (1): 2019922. ( PubMed, DOI )

  24. Okada R, Furusawa A, Choyke PL, Kobayashi H.. Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence Imaging Methods in Molecular Biology. 2022; 2525 3-13. ( PubMed )

  25. Kato T, Okada R, Goto Y, Furusawa A, Inagaki F, Wakiyama H, Furumoto H, Daar D, Turkbey B, Choyke PL, Takakura H, Inanami O, Ogawa M, Kobayashi H. Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy. ACS pharmacology & translational science. 2021.10; 4 (5): 1689-1701. ( PubMed, DOI )

  26. Kato T, Okada R, Furusawa A, Inagaki F, Wakiyama H, Furumoto H, Okuyama S, Fukushima H, Choyke PL, Kobayashi H. Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models. Molecular cancer therapeutics. 2021.09; ( PubMed, DOI )

  27. Okada R, Furusawa A, Inagaki F, Wakiyama H, Kato T, Okuyama S, Furumoto H, Fukushima H, Choyke PL, Kobayashi H. Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model. Cancer science. 2021.08; 112 (8): 3041-3049. ( PubMed, DOI )

  28. Kurebayashi Y, Olkowski CP, Lane KC, Vasalatiy OV, Xu BC, Okada R, Furusawa A, Choyke PL, Kobayashi H, Sato N. Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression. Cancer research. 2021.06; 81 (11): 3092-3104. ( PubMed, DOI )

  29. Okada R, Furusawa A, Vermeer DW, Inagaki F, Wakiyama H, Kato T, Nagaya T, Choyke PL, Spanos WC, Allen CT, Kobayashi H. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials. EBioMedicine. 2021.05; 67 103345. ( PubMed, DOI )

  30. Okada R, Kato T, Furusawa A, Inagaki F, Wakiyama H, Choyke PL, Kobayashi H. Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity. Advanced therapeutics. 2021.05; 4 (5): ( PubMed, DOI )

  31. Wu S, Okada R, Liu Y, Fang Y, Yan F, Wang C, Li H, Kobayashi H, Chen Y, Tang Q. Quantitative analysis of vascular changes during photoimmunotherapy using speckle variance optical coherence tomography (SV-OCT). Biomedical optics express. 2021.04; 12 (4): 1804-1820. ( PubMed, DOI )

  32. Inagaki FF, Fujimura D, Furusawa A, Okada R, Wakiyama H, Kato T, Choyke PL, Kobayashi H. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. Molecular pharmaceutics. 2021.03; 18 (3): 1238-1246. ( PubMed, DOI )

  33. Inagaki FF, Fujimura D, Furusawa A, Okada R, Wakiyama H, Kato T, Choyke PL, Kobayashi H. Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green. Cancer science. 2021.03; 112 (3): 1326-1330. ( PubMed, DOI )

  34. Shuhei Okuyama, Daiki Fujimura, Fuyuki Inagaki, Ryuhei Okada, Yasuhiro Maruoka, Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi. Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green Cancer Diagnosis & Prognosis. 2021; 1 (2): 29-34.

  35. Koh Miwa, Masahiro Tsutsumi, Keiko Fukino, Kohtaro Eguchi, Ryuhei Okada, Keiichi Akita. An anatomical study of the anterior wall of the hypopharyngeal and the cervical esophageal junction. Auris Nasus Larynx. 2020.10; 47 (5): 849-855. ( PubMed, DOI )

  36. Maruoka Y, Furusawa A, Okada R, Inagaki F, Fujimura D, Wakiyama H, Kato T, Nagaya T, Choyke PL, Kobayashi H. Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models Vaccines (Basel). 2020.09; 8 (3): 528.

  37. Adrian Rosenberg, Fuyuki Inagaki, Takuya Kato, Ryuhei Okada, Hiroaki Wakiyama, Aki Furusawa, Peter L Choyke, Hisataka Kobayashi. Wound healing after excision of subcutaneous tumors treated with near-infrared photoimmunotherapy. Cancer Med. 2020.08; 9 (16): 5932-5939. ( PubMed, DOI )

  38. Adrian Rosenberg, Daiki Fujimura, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Peter L Choyke, Hisataka Kobayashi. Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice. Mol Imaging. 2020.07; 19 1536012120934965. ( PubMed, DOI )

  39. Fuyuki F Inagaki, Daiki Fujimura, Sara Ansteatt, Ryuhei Okada, Aki Furusawa, Peter L Choyke, Marcin Ptaszek, Hisataka Kobayashi. Effect of Short PEG on Near-Infrared BODIPY-Based Activatable Optical Probes. ACS Omega. 2020.06; 5 (25): 15657-15665. ( PubMed, DOI )

  40. Zeliang Zheng, Ryuhei Okada, Hisataka Kobayashi, Tadanobu Nagaya, Junxia Wei, Qi Zhou, Fred Lee, Tapan K Bera, Yun Gao, William Kuhlman, Chin-Hsien Tai, Ira Pastan. Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity. Mol Cancer Ther. 2020.03; 19 (3): 812-821. ( PubMed, DOI )

  41. Xui-Fen Liu, Junxia Wei, Qi Zhou, Bruce A Molitoris, Ruben Sandoval, Hisataka Kobayashi, Ryuhei Okada, Tadanobu Nagaya, Baktiar Karim, Donna Butcher, Ira Pastan. Immunotoxin SS1P is rapidly removed by proximal tubule cells of kidney, whose damage contributes to albumin loss in urine. Proc Natl Acad Sci U S A. 2020.03; 117 (11): 6086-6091. ( PubMed, DOI )

  42. Yasuhiro Maruoka, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Daiki Fujimura, Hiroaki Wakiyama, Takuya Kato, Tadanobu Nagaya, Peter L Choyke, Hisataka Kobayashi. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models. Cancer Immunol Res. 2020.03; 8 (3): 345-355. ( PubMed, DOI )

  43. Wakiyama H, Furusawa A, Okada R, Inagaki F, Kato T, Maruoka Y, Choyke PL, Kobayashi H.. Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy. Cancers (Basel). 2020; 12 (12): E3747.

  44. Fujimura D, Inagaki F, Okada R, Rosenberg A, Furusawa A, Choyke PL, Kobayashi H. Conjugation Ratio, Light Dose, and pH Affect the Stability of Panitumumab-IR700 for Near-Infrared Photoimmunotherapy. ACS Medicinal Chemistry Letters. 2020; 6 (11(8)): 1598-1604.

  45. Maruoka Y, Furusawa A, Okada R, Inagaki F, Wakiyama H, Kato T, Nagaya T, Choyke PL, Kobayashi H. Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors. Cancers (Basel). 2020; 10 (12(9)): 2575.

  46. Yu A Nakamura, Shuhei Okuyama, Aki Furusawa, Tadanobu Nagaya, Daiki Fujimura, Ryuhei Okada, Yasuhiro Maruoka, Philip C Eclarinal, Peter L Choyke, Hisataka Kobayashi. Near-infrared photoimmunotherapy through bone. Cancer Sci.. 2019.12; 110 (12): 3689-3694. ( PubMed, DOI )

  47. Ryuhei Okada, Yasuhiro Maruoka, Aki Furusawa, Fuyuki Inagaki, Tadanobu Nagaya, Daiki Fujimura, Peter L Choyke, Hisataka Kobayashi. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy. Bioconjug. Chem.. 2019.10; 30 (10): 2624-2633. ( PubMed, DOI )

  48. Ryuhei Okada, Taku Ito, Fuminori Nomura, Susumu Kirimura, Yuichiro Cho, Masaki Sekine, Yumiko Tateishi, Yosuke Ariizumi, Takahiro Asakage. The quantitative analysis of the human papillomavirus DNA load in submandibular gland lesions with droplet digital polymerase chain reaction. Acta Otolaryngol.. 2019.01; 139 (1): 105-110. ( PubMed, DOI )

  49. Fusa Ogata, Tadanobu Nagaya, Yasuhiro Maruoka, Joshua Akhigbe, Adam Meares, Melissa Y Lucero, Andrius Satraitis, Daiki Fujimura, Ryuhei Okada, Fuyuki Inagaki, Peter L Choyke, Marcin Ptaszek, Hisataka Kobayashi. Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer. Bioconjug. Chem.. 2019.01; 30 (1): 169-183. ( PubMed, DOI )

  50. Mochida A, Ogata F, Maruoka Y, Nagaya T, Okada R, Inagaki F, Fujimura D, Choyke PL, Kobayashi H. Pitfalls on sample preparation for <i>ex vivo</i> imaging of resected cancer tissue using enzyme-activatable fluorescent probes. Oncotarget. 2018.11; 9 (89): 36039-36047. ( PubMed, DOI )

  51. Kenro Kawada, Taro Sugimoto, Ryuhei Okada,Kazuya Yamaguchi, Yudai Kawamura,Masafumi Okuda, Yuuichiro Kume,Andres Mora,Tairo Ryotokuji,Takuta Okada,Akihiro Hoshino,Yutaka Tokairin,Yausaki Nakajima,Yusuke kiyokawa,Fuminori Nomura,Yosuke Ariizumi, Shohei Tomii, Takashi Ito, Takahiro Asakage, Yusuke Kinugasa, Tatsuyuki Kawano. A case of simultaneous triple primary cancers of the hypopharynx, esophagus and stomach which were dissected by endoscopic laryngo-pharyngeal surgery combined with endoscopic submucosal dissection Open Journal of Gastroenterilogy. 2018.03; 8 (3): 94-102. ( DOI )

  52. kawada k, Kawano T, Okada T, Yamaguchi K,Kawamura Y, Matsui T,Okuda M,Ogo T,Kume Y,Nakajima Y,Anderes Mora,Hoshino A, Tokairin Y, Nakajima Y,Okada R,Kiyokawa Y,Nomura F,Ariizumi Y,Sugimoto T,Asakage T,Ito T. The usefullness of intra-oropharyngeal U-turm method using trans-nasal endoscopy for detecting superficial squamous cell carcinoma of the base of the tongue J Otolaryngol ENT Res. 2017.08; 8 240.

  53. kawada k, Kawano T, Sugimoto T，Yamaguchi K,Kawamura Y，Matsui　T，Okuda M，Ogo T,Kume　Y，Nakajima　Y，Andres Mora, Okada T,Hoshino A, Tokairin Y,Nakajima Y,Okada R,Kiyokawa Y,Nomura F,Asakage T,Shimoda R,Ito T. Case of suprficial cancer located at the pharyngoesophageal jinction which was dissected by endoscopic laryngopharyngeal surgery combined with endoscopic submucosal dissection Case Rep Otolaryngol. 2017.08; ( DOI )

  54. Okada R, Muro S, Eguchi K, Yagi K, Nasu H, Yamaguchi K, Miwa K, Akita K . The extended bundle of the tensor veli palatini: Anatomic consideration of the dilating mechanism of the Eustachian tube. Auris Nasus Larynx. 2017.06;

  55. Kawada K, Kawano T, Sugimoto T, Yamaguchi K, Kawamura Y, Matsui T, Okuda M, Ogo T, Kume Y, Nakajima Y, Mora A, Okada T, Hoshino A, Tokairin Y, Nakajima Y, Okada R, Kiyokawa Y, Nomura F, Asakage T, Shimoda R, Ito T. Case of Superficial Cancer Located at the Pharyngoesophageal Junction Which Was Dissected by Endoscopic Laryngopharyngeal Surgery Combined with Endoscopic Submucosal Dissection. Case reports in otolaryngology. 2017; 2017 1341059. ( PubMed, DOI )

  56. 江口 紘太郎, 鈴木 政美, 井田 翔太, 川田 倫之, 岡田 隆平, 新國 摂, 朝蔭 孝宏. Diagnosis 側頸嚢胞および嚢胞状転移性リンパ節の内容液アミラーゼ・サイログロブリン測定による鑑別診断(Diagnosing Lateral Cervical Cyst and Cystic Lymph Node Metastasis by Measuring Amylase and Thyroglobulin in the Fluid Content) 頭頸部癌. 2015.10; 41 (3): 335-338.

  57. Kiyokawa J, Yamaguchi K, Okada R, Maehara T, Akita K. Origin, course and distribution of the nerves to the posterosuperior wall of the external acoustic meatus. Anat Sci Int. 2014.09; 89 (4): 238-245.

  58. Suzuki M, Tsunoda A, Kudo T, Okada R, Toyoda M. Successful management of hypoparathyroidism following total thyroidectomy with vitamin D(3) alone. Auris Nasus Larynx. 2014.02; 41 (1): 53-55.

  59. Ryuhei Okada, Masami Suzuki, Koji Takeuchi, Hiroyuki Horikoshi, Atsunobu Tsunoda. Measurement of shear wave velocities coupled with an evaluation of elasticity using ARFI elastography in diagnosis of papillary thyroid carcinoma OJCD. 2013.12; 3 (4): 178-182.

  60. 永久泰斉，岡田隆平，大西威一郎，朝蔭孝宏. 集学的治療が奏効した悪性ラブドイド腫瘍の症例 JOHNS. 2025.02; 41 (2): 251-255.

  61. 岡田 隆平. 頭頸部アルミノックス治療の原理と臨床 日本耳鼻咽喉科免疫アレルギー感染症学会誌. 2024.12; 4 (4): 201-206. ( DOI )

  62. 川田 研郎, 河邊 浩明, 岡田 隆平, 坂野 正佳, 小郷 泰一, 藤原 尚志, 大野 十央, 春木 茂男, 國枝 純子, 朝蔭 孝宏. 【症例から学ぶ咽頭・食道ESD】咽頭表在癌のESD/ELPS　下咽頭癌が喉頭にまで及んでいる 消化器内視鏡. 2024.08; 36 (8): 1145-1150. ( 医中誌 )

  63. 岡田 隆平. 【新たに注目される頭頸部癌治療】光免疫療法　光免疫療法の原理と基礎 JOHNS. 2023.11; 39 (11): 1374-1377. ( 医中誌 )

  64. 川島 慶之, 瀬越 空人, 伊藤 卓, 有泉 陽介, 大野 十央, 藤川 太郎, 田崎 彰久, 西尾 綾子, 本田 圭司, 岡田 隆平, 立石 優美子, 河邊 浩明, 朝蔭 孝宏, 堤 剛. 外耳道癌79症例の早期臨床像 日本耳鼻咽喉科頭頸部外科学会会報. 2023.09; 126 (9): 1052-1060. ( 医中誌 )

  65. 川田 研郎, 河邊 浩明, 春木 茂男, 藤原 尚志, 小郷 泰一, 坂野 正佳, 奥野 圭祐, 谷岡 利朗, 徳永 正則, 大野 十央, 田崎 彰久, 岡田 隆平, 伊藤 崇, 朝蔭 孝宏, 絹笠 祐介. 【知っておくべき口腔・咽喉頭病変】咽喉頭表在癌の内視鏡的診断　経鼻内視鏡の立場から 胃と腸. 2023.09; 58 (9): 1120-1127. ( 医中誌 )

  66. 岡田 隆平. Head and Neck Tumor頭頸部腫瘍　頭頸部癌の光免疫療法(アルミノックス治療)　光免疫療法の将来展望 癌と化学療法. 2023.07; 50 (7): 794-798. ( 医中誌 )

  67. 岡田 隆平, 長尾 俊景, 金井 光, 朝蔭 孝宏. 症例をどうみるか　シスプラチン+5-FU+セツキシマブ療法開始3年後にt-MDSを発症した1例 JOHNS. 2022.11; 38 (11): 1517-1521.

  68. 河邊 浩明, 大野 十央, 川田 研郎, 高橋 亮介, 立石 優美子, 岡田 隆平, 有泉 陽介, 杉本 太郎, 朝蔭 孝宏. 内視鏡的咽喉頭手術を施行した下咽頭類基底細胞癌の2例 日本気管食道科学会会報 . 2022.06; 73 (3): 222-230. ( DOI )

  69. 岡田 隆平, 大野 十央, 高橋 亮介, 河邊 浩明, 立石 優美子, 有泉 陽介, 堤 剛, 朝蔭 孝宏. 頭蓋底転移で発見された甲状腺低分化癌例 耳鼻咽喉科臨床. 2022.02; 115 (2): 159-165. ( DOI )

  70. 川田 研郎, 河邊 浩明, 大野 十央, 岡田 隆平, 田崎 彰久, 篠原 元, 塩原 寛之, 角田 龍太, 齋藤 賢将, 藤原 直人, 星野 明弘, 徳永 正則, 絹笠 祐介, 杉本 太郎, 朝蔭 孝宏. 【咽頭表在癌の内視鏡診断と治療】咽頭表在癌の治療選択とその実際　ESD/ELPSを中心に 胃と腸. 2021.10; 56 (11): 1419-1426. ( 医中誌 )

  71. 岡田 隆平. 【イラスト&画像で各科の手術がバッチリ!オペナースのための"イイトコ取り"解剖図】(第8章)耳鼻咽喉科　まずはここを知る!解剖図　頸部、喉頭 オペナーシング. 2018.09; (2018秋季増刊): 210-211. ( 医中誌 )

  72. 川田 倫之, 岡田 隆平, 鈴木 政美, 寺内 祐理, 高橋 亮介. 膵転移をきたした甲状腺乳頭癌の1例 耳鼻咽喉科・頭頸部外科. 2018.05; 90 (6): 483-488. ( 医中誌 )

  73. 川田 研郎, 岡田 卓也, 中島 康晃, 山口 和哉, 川村 雄大, 奥田 将史, 久米 雄一郎, 了徳寺 大郎, 星野 明弘, 東海林 裕, 岡田 隆平, 清川 佑介, 有泉 陽介, 朝蔭 孝宏, 伊藤 崇, 河野 辰幸. 【咽頭・頸部食道癌の診断と治療】咽頭癌の内視鏡診断　経鼻内視鏡 胃と腸. 2017.12; 52 (13): 1665-1673. ( 医中誌 )

  74. 岸川 正大, 大野 十央, 末松 由愛, 岡田 隆平, 朝蔭 孝宏. 耳下腺に発生したオンコサイトーマの2例 頭頸部外科. 2017.10; 27 (2): 247-252.

  75. 野村 文敬, 杉本 太郎, 川田 研郎, 角 卓郎, 有泉 陽介, 清川 佑介, 田崎 彰久, 岡田 隆平, 服部 夏子, 河野 辰幸, 岸本 誠司, 朝蔭 孝宏. セツキシマブ併用放射線療法を施行した下咽頭癌症例に対する経口的救済手術の検討 頭頸部癌. 2017.04; 43 (1): 28-32.

  76. 鈴木政美, 江口紘太郎, 井田翔太, 岡田隆平, 川田倫之, 工藤毅. 舌癌における外側舌リンパ節転移の検討と舌リンパ節の臨床的分類 頭頸部外科. 2016.06; 26 (1): 71-78.

  77. 新國摂, 鈴木政美, 川田倫之, 江口紘太郎, 岡田隆平. 口蓋扁桃転移を来した原発性肺癌例とその臨床的特徴 頭頸部癌. 2016.04; 42 (1): 34-38.

  78. 岡田隆平, 伊藤京子, 岸川正大, 大野十央. 内視鏡補助下に頸部外切開で切除した気管内毛細血管腫の1例 頭頸部外科. 2016.02; 25 (3): 481-485.

  79. 角田篤信, 岡田隆平, 角卓郎, 秋田恵一, 山口久美子. 解剖体を用いた耳鼻咽喉科卒前臨床教育 耳鼻咽喉科臨床. 2016.01; 109 (1): 63-67.

  80. 岡田隆平, 秋田恵一. 【頭蓋底外科の進歩-オープンサージェリーと内視鏡下手術】 頭蓋底手術に必要な臨床解剖　顔面からみた頭蓋底の臨床解剖 JOHNS. 2015.07; 31 (7): 838-841. ( 医中誌 )

  81. 工藤 毅, 鈴木 政美, 岡田 隆平. 頸部郭清術前後における鎖骨下静脈の位置と血管径の変化　中心静脈カテーテル留置の適否について 頭頸部外科. 2013.02; 22 (3): 345-349.

  82. 鈴木 政美, 工藤 毅, 岡田 隆平, 豊田 実, 岡本 彩子. 両頸部郭清と甲状腺片葉切除を施行した下咽頭癌の副甲状腺(上皮小体)機能温存について 頭頸部外科. 2012.10; 22 (2): 203-208.

  83. 岡田 隆平, 角田 篤信, 籾山 直子, 岸根 有美, 喜多村 健, 岸本 誠司, 秋田 恵一. Thiel法による解剖体固定法とその有用性についての検討 日本耳鼻咽喉科学会会報. 2012.08; 115 (8): 791-794.

  84. 清川 佑介, 有泉 陽介, 野村 文敬, 田崎 彰久, 岡田 隆平, 角田 篤信, 岸本 誠司, 朝蔭 孝宏. 側頭部の線維性骨異形成症から生じた骨肉腫例 耳鼻咽喉科臨床. 2017.11; 10 (11): 765-771.

< 前のページ - 次のページ >

  • 1
このページの先頭へ▲